The advent of oncolytic virotherapy in oncology: The Rigvir® story
Work
Year: 2018
Type: review
Abstract: Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour e... more
Source: European Journal of Pharmacology
Cites: 83
Cited by: 139
Related to: 10
FWCI: 1.953
Citation percentile (by year/subfield): 99.92
Subfield: Genetics
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $2,790